Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Uber Technologies, Inc. (UBER): A Hot Growth Stock to Buy According to Hedge Funds

We recently compiled a list of the 8 Hot Growth Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Uber Technologies, Inc. (NYSE:UBER) stands against the other hot growth stocks.

A month before the election that spelled Donald Trump’s victory, the U.S. Bureau of Labor Statistics released a report showing a robust labor market with rising wages, a decrease in unemployment, and the addition of 254,000 jobs in September. The unemployment rate fell to 4.1% in September, down from 4.2% in August and 4.3% in July. Earlier concerns arose when the unemployment rate increased, leading some economists to worry that the Federal Reserve’s decision not to cut interest rates impacted the labor market.

However, the Fed eased those concerns in September by cutting the federal funds rate by half a percentage point. The Fed had initially raised rates aggressively beginning in March 2022 to combat inflation, pausing mid-2023. While inflation has cooled significantly since peaking in June 2022, economists note the high rates continue to impact the economy, especially the housing market. That said, Fed Chair Jerome Powell addressed the housing market on September 30, noting that he expects housing inflation to keep easing and that overall economic conditions are conducive to further disinflation.

On another note, while September’s Consumer and Producer Price Indexes aligned with expectations, signaling that inflation is trending toward the Federal Reserve’s 2% target, economists at Goldman believe the Fed may have already reached that goal. The investment bank forecasts that the Commerce Department’s Personal Consumption Expenditures (PCE) price index for September will show a 12-month inflation rate of 2.04%. If accurate, this figure would be rounded down to 2%, aligning perfectly with the Fed’s long-standing objective. This would come just over two years after inflation surged to a 40-year high, prompting a series of aggressive interest rate hikes. Moreover, the S&P 500 has gained 4% since the Fed’s rate initial cut last month, as investors have poured over $20 billion into U.S. stock funds.

Both Fundstrat and Goldman raised their year-end stock market forecasts in week 41 of this year, with Goldman predicting an additional 2% rise after the S&P 500 exceeded its previous target. This would cap off an already strong year, with the index up more than 20%. A key driver behind the forecasts for continued stock price growth is the expectation that a broader range of industries will contribute to the market’s rise. However, in reality, indexes like the S&P 500 remain largely dependent on investor enthusiasm for tech, particularly in the realm of artificial intelligence. On that note, the bank also pointed to a recovering microchip supply chain, which is expected to lift profits for both chipmakers and tech giants as they develop new AI applications.

While historical performance isn’t always a reliable indicator, seasonal trends suggest that Q4 often boosts the broader U.S. markets, partly driven by increased consumer spending during the holiday season. Market analysts also note that growth stocks tend to perform well when global interest rates reverse course. However, Adam Parker, CEO of Trivariate Research, shared in an interview with CNBC that he feels more pessimistic about growth stocks compared to his outlook before August 5 lows, citing the unusual market conditions and a slight dip in corporate earnings growth projections.

Moreover, despite high expectations that interest rate cuts by the Federal Reserve would boost the stock market, this hasn’t materialized as anticipated. Investors seem to be increasingly sensitive to growth concerns amid a global landscape marked by the U.S. presidential election, Middle East instability, and an uncertain Fed rate outlook for next year. While the Fed has hinted at more rate cuts, moving too quickly could jeopardize inflation goals. Regarding this, analysts at Stifel made the following remarks:

“The conclusion … is that if the Fed cuts rates in 2025 absent a recession (two 25’s as this year comes to a close do not count) then that would be a mistake, with investors paying the price in latter 2025 / 2026, based on historical precedent.”

In terms of making money in the stock market, most investors are naturally drawn to growth stocks. While defensive investments are gaining traction due to global economic slowdown, Andrew Slimmon of Morgan Stanley Investment Management advises against this approach. These sentiments emphasize that high-growth stocks can outperform the market and deliver strong returns even if the stock fluctuates during the short term. Many of these stocks have shown impressive revenue growth and, with key catalysts in place, may continue to outperform.

Additionally, hedge funds see the most promising growth stocks as those positioned to benefit from rising consumer purchasing power. As the Fed aims for a soft economic landing, consumer cyclical stocks may gain, bolstered by improved consumer spending. Rate cuts should also support growth and tech stocks, setting the stage for potential gains across these sectors. In that same vein, the average annual return for the 500 largest-cap companies has consistently exceeded 10%, giving investors strong confidence to favor the stock market over more conservative options like bonds or fixed-income securities.

Our Methodology

In this article, we compiled a list of the top growth stocks with year-to-date gains exceeding 20%. These hot stocks to buy are ranked in ascending order based on hedge fund sentiment, offering a clear view of which growth stocks are most favored by institutional investors.

At Insider Monkey, we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

A close up view of a hand holding a smartphone, using a ride sharing app.

Uber Technologies, Inc. (NYSE:UBER)

Year-To-Date Gain as of November 6: 25.47%

Number of Hedge Fund Holders: 145

Uber Technologies, Inc. (NYSE:UBER) is a global leader in ride-hailing, food delivery, and freight services, transforming urban transportation by connecting users with drivers via its app since its inception.

Notably, Uber Technologies, Inc. (NYSE:UBER) has announced a partnership with autonomous tech startup Avride to enhance its self-driving capabilities. Uber Eats will deploy Avride’s sidewalk delivery robots in Austin, with plans to expand to Dallas and Jersey City. Additionally, Uber Technologies, Inc. (NYSE:UBER) aims to launch robotaxi services in Dallas next year.

In that same vein, On October 11, Jefferies reiterated its Buy rating and $100 price target for Uber Technologies, Inc. (NYSE:UBER) following Tesla’s unveiling of the Cybercab at its robotaxi event. Tesla plans to implement full self-driving technology in its Model 3 and Model Y by 2025 in California and Texas, with Cybercab production slated for 2027. Analysts view this as a positive development for Uber’s ride-hailing business.

Overall UBER ranks 2nd on our list of the hot growth stocks to buy according to hedge funds. While we acknowledge the potential of UBER as an investment, our conviction lies in the belief that certain AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than UBER but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 70%.

For a ridiculously low price of just $29, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

 

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $29.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!


No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a year later!

Penicillin Changed the World. This Drug Could Too

This Clinical-stage Biotech Company is Taking a Revolutionary Approach to Eradicating Many Respiratory Viruses Including a single drug to treat COVID, RSV, FLU and even Monkey-pox!

This is a clinical-stage, global leader in broad-spectrum antiviral nanomedicines who is developing therapeutic drugs that work safely and effectively, even against emerging variants!

A novel broad-spectrum antiviral

NV-387,  a drug that  treats RSV, COVID-19, Long COVID, Influenza, Bird Flu H5N1, and other respiratory viral infections as well as Monkey-pox, has successfully completed Phase 1 clinical trials in healthy subjects with no reported adverse events, even at the highest and repeated dosages. Remarkably, the company has been able to develop NV-387 for oral administration already, as well as for injectable and inhalation formulations to enable many modes of use. The Company is currently focused on advancing NV-387 into Phase II human clinical trials for the treatment of RSV infection.

Susceptible viruses CANNOT escape NV-387, even as they continue to evolve in the field into variants. Why? Because  no matter how much the virus changes, it continues to use the same host-side signature to bind to and cause infection in the hosts, and thus the nanoviricide would be anticipated to continue to be effective even as the virus mutates to generate variants.

Click to continue reading…